Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Wang
Guofeng Chen
George Lau

Showing results (1-10 of 7,953) with videos related to

Pageof 796
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2016
ReplyCheng Wang, Guofeng Chen, George Lau
Hepatology (Baltimore, Md.)|February 15, 2017
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysisGuofeng Chen, Cheng Wang, Jing Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Treatment of chronic hepatitis B infection-2017Guo-Feng Chen, Cheng Wang, George Lau
Hepatology (Baltimore, Md.)|October 29, 2017
ReplyGuo-Feng Chen, Cheng Wang, George Lau
Annals of Saudi Medicine|October 27, 2015
Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virusShao Qing, Dong Ji, Bing Li, et al.
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Shortening HCV therapy: science meets public healthGeorge Lau
Hepatology International|November 20, 2024
Rechallenge with immune checkpoint inhibitors therapy for patients with HCC-lot more to learnGeorge Lau
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral AgentsCheng Wang, Dong Ji, Jing Chen, et al.
Clinical Liver Disease|March 8, 2024
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challengesJing Chen, George Lau
Hepatology International|May 25, 2020
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations, George Lau, Manoj Sharma
Pageof 796

Showing results (1-10 of 7,953) with videos related to

Sort By:
Pageof 796
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2016
ReplyCheng Wang, Guofeng Chen, George Lau
Hepatology (Baltimore, Md.)|February 15, 2017
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysisGuofeng Chen, Cheng Wang, Jing Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Treatment of chronic hepatitis B infection-2017Guo-Feng Chen, Cheng Wang, George Lau
Hepatology (Baltimore, Md.)|October 29, 2017
ReplyGuo-Feng Chen, Cheng Wang, George Lau
Annals of Saudi Medicine|October 27, 2015
Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virusShao Qing, Dong Ji, Bing Li, et al.
The Lancet. Gastroenterology & Hepatology|August 14, 2017
Shortening HCV therapy: science meets public healthGeorge Lau
Hepatology International|November 20, 2024
Rechallenge with immune checkpoint inhibitors therapy for patients with HCC-lot more to learnGeorge Lau
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2016
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral AgentsCheng Wang, Dong Ji, Jing Chen, et al.
Clinical Liver Disease|March 8, 2024
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challengesJing Chen, George Lau
Hepatology International|May 25, 2020
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations, George Lau, Manoj Sharma
Pageof 796